Literature DB >> 14496914

The role of immunity in the pathogenesis of experimental hematogenous pyelonephritis.

J P SANFORD, B W HUNTER, L L SOUDA.   

Abstract

Hematogenous pyelonephritis was produced in rats utilizing multiple strains of Escherichia coli, a strain of Klebsiella pneumoniae, and a strain of Proteus mirabilis. Three patterns of hematogenous pyelonephritis occurred which represent an interrelationship between an immune response to the infecting bacteria and the development of obstructive uropathy as a consequence of infection. First, the course of pyelonephritis due to strains of Escherichia coli was acute, self-limited, and associated with the development of circulating agglutinins. Following healing, this pattern of infection was associated with acquired resistance to reinfection with the same bacterial strain. Second, the course of pyelonephritis due to a strain of Klebsiella pneumoniae type C was chronic. This infection was not associated with the production of circulating agglutinins against encapsulated strains. Acquired resistance to reinfection by the homotypic strain could not be demonstrated following eradication of infection but was produced by the passive transfer of concentrated antiserum. Third, pyelonephritis due to Proteus mirabilis was associated with circulating agglutinins and resistance to reinfection with the same organism following eradication of infection, yet the course was chronic. The chronicity appeared to be the consequence of obstructive uropathy resulting from calculi which developed during the course of the infection. Resistance to reinfection was demonstrated in infections with strains of E. coli and P. mirabilis. The resistance is associated with specific immunity as demonstrated by the observation that: (a) it is type-specific, (b) it is of at least 3 months' duration, and (c) it can be passively transferred by means of rabbit antiserum. Since K. pneumoniae failed to evoke capsular antibodies in the rat, resistance to infection with K. pneumoniae was produced only by means of passively transferred concentrated rabbit antiserum and not by prior infection. Immunity can be demonstrated to have a significant role in the pathogenesis of experimental hematogenous pyelonephritis only in the absence of obstructive uropathy.

Entities:  

Keywords:  PYELONEPHRITIS/immunology

Mesh:

Substances:

Year:  1962        PMID: 14496914      PMCID: PMC2137485          DOI: 10.1084/jem.115.2.383

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Tolerance to bacterial endotoxin produced by proliferation of gram negative bacteria in the kidney.

Authors:  W R MCCABE
Journal:  Proc Soc Exp Biol Med       Date:  1961-06

2.  Effects of antibiotics and vaccination on experimental pyelonephritis.

Authors:  H M WEYRAUCH; M L ROSENBERG; A D AMAR; M REDOR
Journal:  J Urol       Date:  1957-11       Impact factor: 7.450

3.  The antibody (hemagglutinin) response of patients with infections of the urinary tract.

Authors:  M H NEEDELL; E NETER; W J STAUBITZ; W A BINGHAM
Journal:  J Urol       Date:  1955-11       Impact factor: 7.450

4.  Homologous and heterologous resistance in mice given bacterial endotoxins.

Authors:  R S ABERNATHY
Journal:  J Immunol       Date:  1957-05       Impact factor: 5.422

5.  Failure of Immunity Responses in Localized Disease.

Authors:  W H Hughes
Journal:  Br Med J       Date:  1945-03-17

6.  The Influence of Endotoxin on Resistance to Infection.

Authors:  A I Braude; J Siemienski
Journal:  Bull N Y Acad Med       Date:  1961-07

7.  Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.

Authors:  M LANDY; L PILLEMER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

8.  Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.

Authors:  S GAINES; M LANDY; G EDSALL; A D MANDEL; R J TRAPANI; A S BENENSON
Journal:  J Exp Med       Date:  1961-09-01       Impact factor: 14.307

9.  Reversible changes in the susceptibility of mice to bacterial infections. I. Changes brought about by injection of pertussis vaccine or of bacterial endotoxins.

Authors:  R J DUBOS; R W SCHAEDLER
Journal:  J Exp Med       Date:  1956-07-01       Impact factor: 14.307

10.  Pyelitis, an important factor in the pathogenesis of retrograde pyelonephritis.

Authors:  B R ANDERSEN; G G JACKSON
Journal:  J Exp Med       Date:  1961-09-01       Impact factor: 14.307

View more
  24 in total

1.  Humoral immunity to gram-negative bacillary infections in experimental animals and man.

Authors:  W R McCabe
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  PATHOGENESIS OF CHRONIC PYELONEPHRITIS. II. EFFECT OF REPETITIVE INFECTION.

Authors:  S C SOMMERS; H C GONICK; G M KALMANSON; L B GUZE
Journal:  Am J Pathol       Date:  1964-11       Impact factor: 4.307

3.  STUDIES OF URINARY TRACT INFECTIONS IN INFANCY AND CHILDHOOD. I. ANTIBODY RESPONSE IN DIFFERENT TYPES OF URINARY TRACT INFECTIONS CAUSED BY COLIFORM BACTERIA.

Authors:  J WINBERG; H J ANDERSEN; L A HANSON; K LINCOLN
Journal:  Br Med J       Date:  1963-08-31

4.  Retrograde Proteus pyelonephritis in rats. Bacteriologic, pathologic and fluorescent-antibody studies.

Authors:  R S COTRAN; E VIVALDI; D P ZANGWILL; E H KASS
Journal:  Am J Pathol       Date:  1963-07       Impact factor: 4.307

5.  ENDOTOXIN TOLERANCE. II. ITS OCCURRENCE IN PATIENTS WITH PYELONEPHRITIS.

Authors:  W R McCabe
Journal:  J Clin Invest       Date:  1963-05       Impact factor: 14.808

6.  P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis.

Authors:  J A Roberts; M B Kaack; G Baskin; T K Korhonen; S B Svenson; J Winberg
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

7.  Renal lysozyme levels in animals developing "sterile pyelonephritis".

Authors:  W W Eudy; S E Burrous; F W Sigler
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

8.  Local immune response in experimental pyelonephritis.

Authors:  J D Lehmann; J W Smith; T E Miller; J A Barnett; J P Sanford
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

9.  Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.

Authors:  B Kaijser; P Larsson; S Olling
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

10.  Studies on the epidemiology of Escherichia coli infections. V. Factors influencing acquisition of specific serologic groups.

Authors:  R H Winterbauer; M Turck; R G Petersdorf
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.